• Cancer immunotherapy based on the activation of tumor-associated macrophages
  • Macrophage phenotypes and functions: defining the rules
  • Using tumor-infiltrating immune cells to predict patient’s survival and response to therapy
  • Development of immunotherapy for lung cancer using patient-derived xenografts (PDX)
  • Cancer immunotherapy using viral vectors for cytokine gene delivery in tumors
  • Development of cancer vaccines based on optimized activation of dendritic cells
Page visits: 2246